AptarGroup, Inc. (Aptar) designs and manufactures drug and consumer product dosing, dispensing and protection technologies globally.
Aptar serves diversified end markets, including pharmaceutical, fragrance, facial skincare, color cosmetics, food, b…
Analysis
Hope premium
AptarGroup, Inc. is priced well ahead of what the underlying numbers justify, a pattern we describe as a hope premium. Worth noting: the cash the business generates has lagged behind what the income statement shows.
On valuation, the picture is fair. The owner-earnings multiple stands at 18.3×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 5% a year, against analyst forecasts of 8%. The price, in other words, assumes less than the experts do.
Growth is moderate; the safety picture is sturdy. The company scores 12/20 on our value-creation score: creating some value. Analysts lean positive.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202333
52
2023202420252026
All-time high
88
Nov 2024
All-time low
33
Jan 2023
Average rank
63
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
43
24
26
34
Price/Earnings
32
14
14
12
Price/Book
41
24
22
32
Dividend Yield
69
48
51
57
Value (overall)
39
22
12
25
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.